Want to see KR:326030 full AI Analyst Report?
SK Biopharmaceuticals Co., Ltd. (326030) Ownership - Who Owns SK Biopharmaceuticals Co., Ltd.?
SK Biopharmaceuticals Co., Ltd. (326030) Ownership Overview
- 1.58% Mutual Funds
- 3.11% ETFs
- 95.31% Public Companies and Individual Investors
The ownership structure of SK Biopharmaceuticals Co., Ltd. (KR:326030) stock is a mix of institutional, retail, and individual investors. Approximately 4.69% of the company’s stock is owned by Institutional Investors, and 95.31% is owned by Public Companies and Individual Investors.
The ownership structure of SK Biopharmaceuticals Co., Ltd. (KR:326030) stock is a mix of institutional, retail, and individual investors. Approximately 4.69% of the company’s stock is owned by Institutional Investors, and 95.31% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 1,261,434 | Institution | 1.61% | 73,505,021 |
| Ishares | 812,130 | Institution | 1.04% | 47,323,627 |
| Vanguard Star Funds | 571,519 | Institution | 0.73% | 33,302,984 |
| Vanguard Tax-managed Funds | 383,144 | Institution | 0.49% | 22,326,184 |
| Vanguard International Equity Index Funds | 166,441 | Institution | 0.21% | 9,698,684 |
| Franklin | 162,949 | Institution | 0.21% | 9,495,201 |
| Schwab | 92,335 | Institution | 0.12% | 5,380,453 |
| Dfa Investment Dimensions Group Inc | 72,715 | Institution | 0.09% | 4,237,176 |
| Dimensional | 44,866 | Institution | 0.06% | 2,614,387 |
| State Street | 22,688 | Institution | 0.03% | 1,322,052 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Star Funds | 571,519 | Institution | 0.73% | 33,302,984 |
| Vanguard Tax-managed Funds | 383,144 | Institution | 0.49% | 22,326,184 |
| Vanguard International Equity Index Funds | 166,441 | Institution | 0.21% | 9,698,684 |
| Dfa Investment Dimensions Group Inc | 72,715 | Institution | 0.09% | 4,237,176 |
| Fidelity Salem Street Trust | 21,603 | Institution | 0.03% | 1,258,828 |
| Fidelity Concord Street Trust | 8,682 | Institution | 0.01% | 505,909 |
| State Street Institutional Investment Trust | 8,337 | Institution | 0.01% | 485,805 |
| Valic Co I | 3,832 | Institution | <0.01% | 223,294 |
| American Century Etf Trust | 1,017 | Institution | <0.01% | 59,262 |
| Eaton Vance Mutual Funds Trust | 600 | Institution | <0.01% | 34,963 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VXUS ETF | 578,082 | Institution | 0.74% | 31,526,370 |
| Vanguard, VEA ETF | 383,144 | Institution | 0.49% | 20,895,182 |
| iShares, IEMG ETF | 348,974 | Institution | 0.45% | 20,295,331 |
| Franklin, GB:FLXK ETF | 110,353 | Institution | 0.14% | 6,423,841 |
| Schwab, SCHF ETF | 92,552 | Institution | 0.12% | 5,387,614 |
| Vanguard, VEU ETF | 91,370 | Institution | 0.12% | 4,982,964 |
| iShares, IXUS ETF | 50,443 | Institution | 0.06% | 2,933,621 |
| Franklin, FLKR ETF | 50,112 | Institution | 0.06% | 2,918,161 |
| Vanguard, VPL ETF | 41,374 | Institution | 0.05% | 2,256,377 |
| Vanguard, VT ETF | 41,242 | Institution | 0.05% | 2,249,178 |
FAQ
What percentage of SK Biopharmaceuticals Co., Ltd. (KR:326030) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.69% of SK Biopharmaceuticals Co., Ltd. (KR:326030) stock is held by institutional investors: 1.58% by mutual funds and 3.11% by ETFs.
What percentage of SK Biopharmaceuticals Co., Ltd. (KR:326030) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.31% of SK Biopharmaceuticals Co., Ltd. (KR:326030) stock is held by public companies and individual investors.
Who owns the most shares of SK Biopharmaceuticals Co., Ltd. (KR:326030)?
Vanguard owns the most shares of SK Biopharmaceuticals Co., Ltd. (KR:326030).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
